TWiV 686: COVID-19 clinical update #38 with Dr. Daniel Griffin
- November 28, 2020
- Tagged as: clinical report, COVID-19, Daniel Griffin, monoclonal antibody, pandemic, remdesivir, SARS-CoV-2, viral, virology, virus, viruses
Daniel Griffin provides his weekly clinical report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron’s monoclonal antibody and more.